RTP Mobile Logo

Wednesday, April 29, 2020, San Antonio, Texas, 6:00 PM – 8:00 PM

Oncology Grand Rounds: Nurse and Physician Investigators Discuss New Agents, Novel Therapies and Actual Cases from PracticeA CNE (NCPD) Symposia Series Associated with the ONS 45th Annual Congress

Prostate Cancer

Update regarding COVID-19

The ONS Board of Directors has made the difficult decision to cancel the 45th Annual ONS Congress scheduled to take place in San Antonio, April 29-May 3, 2020. ONS is exploring alternatives for delivering the educational sessions. For up-to-date information on this program, please sign up for our email alerts.

Last updated 4/8/2020

Event Details

Grand Hyatt San Antonio
600 East Market Street
San Antonio, TX 78205

Hotel Phone: (210) 224-1234

Meeting Room
Texas Ballroom ABC (Fourth Floor)
5:30 PM – 6:00 PM
Registration and Dinner Buffet

6:00 PM – 8:00 PM
Educational Program
There is no registration fee for this event. Preregistration is highly recommended as seating and meal service are limited.

Peter H O’Donnell, MD
Assistant Professor, Department of Medicine
Section of Hematology/Oncology
Genitourinary Oncology Program
The University of Chicago
Chicago, Illinois

Kara Olivier, MNP
Massachusetts General Hospital
Harvard Medical School
Boston, Massachusetts

Victoria Sinibaldi, RN, MS, CS, CANP, BC
Adult and Geriatric Nurse Practitioner
Research Associate in Oncology and Urology
Faculty, School of Medicine
Johns Hopkins University
Affiliate Staff, Johns Hopkins Hospital
Baltimore, Maryland

Matthew R Smith, MD, PhD
Claire and John Bertucci Endowed Chair in Genitourinary Cancers
Professor of Medicine
Harvard Medical School
Director, Genitourinary Malignancies Program
Massachusetts General Hospital Cancer Center
Boston, Massachusetts

Neil Love, MD
Research To Practice
Miami, Florida
Meeting space has been assigned to provide a satellite symposium supported by Astellas and Pfizer, Bayer HealthCare Pharmaceuticals, Janssen Biotech Inc, administered by Janssen Scientific Affairs LLC, and Sanofi Genzyme during the Oncology Nursing Society’s (ONS) 45th Annual Congress, April 29 to May 3, 2020 in San Antonio, Texas. The Oncology Nursing Society’s assignment of meeting space does not imply product endorsement.


Topics for Discussion

  • Module 1: Optimal Integration of Novel Antiandrogens into the Management of Nonmetastatic Castration-Resistant Prostate Cancer (CRPC)
  • Module 2: Recognizing and Managing the Side Effects of Hormonal Agents Used in the Management of PC
  • Module 3: Current and Emerging Strategies in the Management of Metastatic Hormone-Sensitive PC
  • Module 4: Current and Evolving Treatment Paradigms in Metastatic CRPC

CE Information

Target Audience
This activity has been designed to meet the educational needs of oncology nurses, nurse practitioners and clinical nurse specialists involved in the treatment of prostate cancer.

Learning Objectives and Goals
Upon completion of this activity, participants should be able to:

  • Apply existing and emerging research data to the therapeutic and supportive care of patients with early and advanced prostate cancer (PC).
  • Evaluate the published research database supporting the recent FDA approvals of secondary hormonal agents in the management of nonmetastatic castration-resistant PC, and apply this information in the discussion of nonresearch treatment options with patients.
  • Counsel patients with hormone-sensitive metastatic PC about the use of cytotoxic and secondary hormonal therapy to ensure appropriate and informed shared decision-making.
  • Recognize how prior therapeutic exposure and patient and disease characteristics may affect the selection and sequencing of available systemic treatments for castration-resistant metastatic PC.
  • Describe the rationale for testing patients with metastatic PC for BRCA1/2 mutations and other related DNA damage repair pathway deficiencies, and advise individuals found to harbor these genetic abnormalities about available clinical trial data documenting the efficacy of PARP inhibition.
  • Educate patients about the side effects associated with approved therapies commonly employed in the management of advanced PC, and provide preventive strategies to reduce or ameliorate these toxicities.
  • Identify opportunities to enhance the collaborative role of oncology nurses in the comprehensive biopsychosocial care of patients with PC to optimize clinical and quality-of-life outcomes.
Accreditation Statement
USF Health is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s (ANCC) Commission on Accreditation.

A maximum of 2 contact hours may be earned by learners who successfully complete this nursing continuing professional development activity.

This activity is awarded 2 ANCC pharmacotherapeutic contact hours.

Participation Completion Requirements
To obtain a certificate of completion and receive credit for this event, nurses must sign in at the registration desk upon arrival, attend the entire activity and return a completed Educational Assessment and Credit Form upon exiting the activity.

Oncology Nursing Certification Corporation (ONCC)/Individual Learning Needs Assessment (ILNA) Certification Information
This activity will be submitted to the ONCC for ILNA verification.

Unlabeled/Unapproved Uses Notice
There is no implied or real endorsement of any product by USF Health, Research To Practice (RTP) or the ANCC. Any off-label use as declared by the FDA will be identified.

Disclosure Policy
USF Health adheres to ACCME and ANCC standards regarding commercial support of continuing medical education. It is the policy of USF Health and Research To Practice that the faculty and planning committee disclose real or apparent conflicts of interest relating to the topics of this educational activity, that relevant conflict(s) of interest are resolved and also that speakers will disclose any unlabeled/unapproved use of drug(s) or device(s) during their presentation. Detailed disclosure will be made in the activity syllabus.

USF Health — USF Health CPD staff have no relevant conflicts of interest to disclose.

RTP CNE (NCPD) planning committee members, staff and reviewers — Planners, scientific staff and independent reviewers for RTP have no relevant conflicts of interest to disclose.

Equal Opportunity Statement
USF is an Equal Opportunity/Affirmative Action/Equal Access Institution.

Contact Information
If you have questions regarding credit, please contact cpdsupport@usf.edu, or call 813-224-7860.

This activity is supported by educational grants from Astellas and Pfizer, Bayer HealthCare Pharmaceuticals, Janssen Biotech Inc, administered by Janssen Scientific Affairs LLC, and Sanofi Genzyme.


Grand Hyatt San Antonio
600 East Market Street
San Antonio, TX 78205

Hotel Phone: (210) 224-1234

Meeting Room
Texas Ballroom ABC (Fourth Floor)

The Grand Hyatt San Antonio is conveniently located adjacent and connected to the Henry B Gonzalez Convention Center, where the ONS 45th Annual Congress is taking place.